MCID: OVR046
MIFTS: 53

Ovarian Cyst

Categories: Cancer diseases, Endocrine diseases, Reproductive diseases

Aliases & Classifications for Ovarian Cyst

Summaries for Ovarian Cyst

MedlinePlus : 43 The ovaries are part of the female reproductive system. They produce a woman's eggs and make female hormones. Ovarian cysts are fluid-filled sacs in or on an ovary. They usually form during ovulation, when the ovary releases an egg. They are usually harmless and go away by themselves. Most women have them sometime during their lives. Most ovarian cysts are small and don't cause symptoms. Women may not find out that they have them until they have a pelvic exam. If there are symptoms, they may include Pressure Bloating Swelling Pain in the lower abdomen, on the side where the cyst is If your health care provider finds a cyst, you may be able to wait to see if it gets bigger. You may need surgery if you have pain, are past menopause, or if the cyst does not go away. If a cyst bursts or causes bleeding, you should get medical help right away. Birth control pills can help prevent new cysts. Rarely, ovarian cysts can become cancerous. This risk increases as you get older. A health problem that involves ovarian cysts is polycystic ovary syndrome (PCOS). Women with PCOS can have high levels of male hormones, irregular or no periods, and small ovarian cysts. Dept. of Health and Human Services Office on Women's Health

MalaCards based summary : Ovarian Cyst, also known as ovarian cysts, is related to corpus luteum cyst and ovarian disease, and has symptoms including pelvic pain An important gene associated with Ovarian Cyst is MUC16 (Mucin 16, Cell Surface Associated), and among its related pathways/superpathways are Regulation of lipid metabolism Insulin signaling-generic cascades and Formation of Fibrin Clot (Clotting Cascade). The drugs Drospirenone and Ethinyl Estradiol have been mentioned in the context of this disorder. Affiliated tissues include ovary, pituitary and uterus, and related phenotypes are endocrine/exocrine gland and homeostasis/metabolism

Disease Ontology : 12 An ovarian disease that is characterized by the presence of a fluid-filled sac and is located in the ovary.

Wikipedia : 76 An ovarian cyst is a fluid-filled sac within the ovary. Often they cause no symptoms. Occasionally they... more...

Related Diseases for Ovarian Cyst

Diseases in the Ovarian Cyst family:

Malignant Ovarian Cyst

Diseases related to Ovarian Cyst via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 146)
# Related Disease Score Top Affiliating Genes
1 corpus luteum cyst 31.9 AFP FOXL2 MUC16
2 ovarian disease 31.4 FOXL2 MUC16 NOBOX PRL VEGFA
3 cystadenocarcinoma 29.7 VEGFA MUC16
4 adenomyosis 29.6 VEGFA PRL
5 neonatal ovarian cyst 12.3
6 malignant ovarian cyst 12.3
7 mccune-albright syndrome 11.4
8 fraser-like syndrome 11.1
9 aromatase deficiency 11.0
10 bleeding disorder, platelet-type, 19 11.0
11 autoimmune oophoritis 11.0
12 lipedematous scalp 11.0
13 ovarian cancer 10.3
14 breast cancer 10.3
15 hypothyroidism 10.2
16 opisthorchiasis 10.2 MUC16 AFP
17 endodermal sinus tumor 10.2 MUC16 AFP
18 endometriosis 10.2
19 juvenile type testicular granulosa cell tumor 10.2 FOXL2 AFP
20 testicular granulosa cell tumor 10.2 FOXL2 AFP
21 hydrocele 10.2 VEGFA AFP
22 male reproductive organ benign neoplasm 10.2 FOXL2 AFP
23 primary peritoneal carcinoma 10.2 VEGFA MUC16
24 peliosis hepatis 10.2 VEGFA AFP
25 telangiectasis 10.2 VEGFA AFP
26 pericardial effusion 10.1 VEGFA MUC16
27 sex cord-gonadal stromal tumor 10.1 FOXL2 AFP
28 placental insufficiency 10.1 VEGFA AFP
29 ovarian brenner tumor 10.1 PRL MUC16
30 serous cystadenocarcinoma 10.1 VEGFA MUC16
31 granulosa cell tumor of the ovary 10.1 PRL FOXL2
32 meningocele 10.1
33 pituitary tumors 10.1 VEGFA PRL
34 intratubular embryonal carcinoma 10.1 PLAU AFP
35 ectopic pregnancy 10.1
36 bile duct disease 10.1 SLC25A13 AFP
37 hyperphenylalaninemia, bh4-deficient, a 10.1 SLC25A13 PRL
38 uterine anomalies 10.0 AFP VEGFA
39 vein disease 10.0 AFP PLAT VEGFA
40 ovarian hyperstimulation syndrome 10.0
41 adenoma 10.0
42 biliary tract disease 10.0 SLC25A13 AFP
43 female reproductive system disease 10.0 VEGFA PRL FOXL2
44 hydronephrosis 10.0
45 leiomyoma 10.0
46 intestinal obstruction 10.0
47 joint disorders 10.0 SERPINB2 PLAU
48 gingivitis 10.0 PLAT SERPINB2
49 lipodermatosclerosis 10.0 PLAT SERPINB2 VEGFA
50 leiomyoma, uterine 9.9

Graphical network of the top 20 diseases related to Ovarian Cyst:



Diseases related to Ovarian Cyst

Symptoms & Phenotypes for Ovarian Cyst

UMLS symptoms related to Ovarian Cyst:


pelvic pain

MGI Mouse Phenotypes related to Ovarian Cyst:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 endocrine/exocrine gland MP:0005379 9.95 AFP FOXL2 NOBOX PLAT PLAU PRL
2 homeostasis/metabolism MP:0005376 9.92 AFP FOXL2 PLAT PLAU PRL SERPINB2
3 growth/size/body region MP:0005378 9.91 FOXL2 NOBOX PLAT PLAU SERPINB2 SLC25A13
4 mortality/aging MP:0010768 9.76 AFP FOXL2 NOBOX PLAT PLAU SERPINB2
5 liver/biliary system MP:0005370 9.65 AFP PLAU PRL SLC25A13 VEGFA
6 neoplasm MP:0002006 9.35 AFP PLAU PRL SERPINB2 VEGFA
7 reproductive system MP:0005389 9.17 AFP FOXL2 NOBOX PLAT PLAU PRL

Drugs & Therapeutics for Ovarian Cyst

Drugs for Ovarian Cyst (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 380)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Drospirenone Approved Phase 4,Phase 3,Phase 1,Not Applicable 67392-87-4 68873
2
Ethinyl Estradiol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 57-63-6 5991
3
Cyproterone Acetate Approved, Investigational Phase 4,Phase 2,Phase 3,Early Phase 1,Not Applicable 427-51-0
4
Polyestradiol phosphate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 28014-46-2
5
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-28-2 5757
6 Estradiol valerate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 979-32-8
7
Metformin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 657-24-9 14219 4091
8
Simvastatin Approved Phase 4,Phase 3,Not Applicable 79902-63-9 54454
9
Resveratrol Approved, Experimental, Investigational Phase 4,Phase 1,Not Applicable 501-36-0 445154
10
Ganirelix Approved Phase 4,Early Phase 1 123246-29-7, 124904-93-4 25081094
11
Orlistat Approved, Investigational Phase 4,Phase 2 96829-58-2 3034010
12
Letrozole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 112809-51-5 3902
13
Pioglitazone Approved, Investigational Phase 4,Not Applicable,Early Phase 1 111025-46-8 4829
14
leucovorin Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 58-05-9 6006 143
15
Acarbose Approved, Investigational Phase 4,Not Applicable 56180-94-0 441184
16
Zinc Approved, Investigational Phase 4,Early Phase 1,Not Applicable 7440-66-6
17
Progesterone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 57-83-0 5994
18
Hydrocortisone acetate Approved, Vet_approved Phase 4,Not Applicable,Early Phase 1 50-03-3
19
Hydrocortisone Approved, Vet_approved Phase 4,Not Applicable,Early Phase 1 50-23-7 5754
20
Testosterone Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-22-0 6013
21
Danazol Approved Phase 4 17230-88-5 28417
22
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
23
Liraglutide Approved Phase 4,Phase 3 204656-20-2 44147092
24
Menotropins Approved Phase 4,Phase 1,Phase 2 61489-71-2, 9002-68-0 5360545
25
Acetylcysteine Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 616-91-1 12035
26
Epinephrine Approved, Vet_approved Phase 4,Not Applicable,Early Phase 1 51-43-4 5816
27
Racepinephrine Approved Phase 4,Not Applicable,Early Phase 1 329-65-7 838
28
Citalopram Approved Phase 4 59729-33-8 2771
29
Alogliptin Approved Phase 4 850649-61-5 11450633
30
Moxonidine Approved, Investigational Phase 4 75438-57-2 4810
31
Nicotinamide Approved, Investigational Phase 4 98-92-0 936
32
Methylcobalamin Approved, Experimental, Investigational Phase 4,Not Applicable 13422-55-4
33
Hydroxocobalamin Approved Phase 4,Not Applicable 13422-51-0 11953898 44475014
34
Leuprolide Approved, Investigational Phase 4,Phase 2,Not Applicable,Early Phase 1 53714-56-0 657181 3911
35
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 1,Phase 2 9004-61-9 53477741
36
Rosiglitazone Approved, Investigational Phase 4,Not Applicable 122320-73-4 77999
37
Exenatide Approved, Investigational Phase 4,Phase 3,Phase 2 141758-74-9 15991534
38
Tamoxifen Approved Phase 4,Phase 3 10540-29-1 2733526
39 tannic acid Approved Phase 4,Phase 2,Not Applicable,Early Phase 1
40
Benzocaine Approved, Investigational Phase 4,Phase 2,Not Applicable,Early Phase 1 94-09-7, 1994-09-7 2337
41
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable,Early Phase 1 1177-87-3
42
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable,Early Phase 1 50-02-2 5743
43
Medroxyprogesterone acetate Approved, Investigational Phase 4,Not Applicable 71-58-9
44
Desogestrel Approved Phase 4,Phase 3 54024-22-5 40973
45
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
46
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
47
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
48
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
49
Toremifene Approved, Investigational Phase 4 89778-26-7 3005573
50
Nitrous oxide Approved, Vet_approved Phase 4 10024-97-2 948

Interventional clinical trials:

(show top 50) (show all 584)
# Name Status NCT ID Phase Drugs
1 The Impact on Ovarian Reserve After Single-port, Two-port, or Four-port Access Laparoscopic Ovarian Cyst Enucleation Unknown status NCT01631253 Phase 4
2 Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants Unknown status NCT02027337 Phase 4 20 mcg ethinylestradiol /3 mg drospirenone;20 mcg ethinylestradiol/3 mg drospirenone and Selmevit;30 mcg ethinylestradiol/3 mg drospirenone;30 mcg ethinylestradiol/3 mg drospirenone and Selmevit;35 mcg ethinylestradiol/2 mg cyproterone;35 mcg ethinylestradiol/2 mg cyproterone and Selmevit
3 Myoinositol for the Treatment of Ovarian and Psychiatric Disorder in Polycystic Ovary Syndrome (PCOS) Patients Unknown status NCT01246310 Phase 4
4 Metformin in Infertile PCOS Patients Unknown status NCT00501904 Phase 4 Metformin
5 the Effect of Diane-35 Pretreatment on In-vitro Fertilization Outcome for Patients With Polycystic Ovary Syndrome Unknown status NCT01752270 Phase 4 Diane-35 pretreatment;Diane-35 pretreatment
6 Effects of Simvastatin and Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients Unknown status NCT02766803 Phase 4 Simvastatin and micronized trans-resveratrol
7 Therapeutic Monitoring of Metformin in Women With Polycystic Ovary Syndrome Unknown status NCT01366391 Phase 4 Metformin
8 Endometrial Scratching During Laproscopic Ovarian Drilling in Subfertile PCOS Women Unknown status NCT02140398 Phase 4
9 Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients Unknown status NCT00417144 Phase 4 Arvekap 0.1mg (Triptorelin, Ipsen, France);Ganirelix 0.25mg (Orgalutran, Organon, The Netherlands)
10 Surgical Ovarian Drilling Versus Hormonal Treatment for Infertility Associated to PolyCystic Ovaries Syndrome (PCOS) Unknown status NCT00378729 Phase 4 Metformin and FSHr
11 Metformin and Gestational Diabetes in High-risk Patients: a RCTs Unknown status NCT00883259 Phase 4 Metformin
12 The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS) Unknown status NCT01475019 Phase 4 Orlistat;Sibutramine
13 Strategies for Ovulation Induction in Anovulatory Infertile Patients With PCOS Unknown status NCT00461643 Phase 4 Clomiphene citrate, metformin, metformin plus clomiphene citrate, gonadotropins
14 The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cyst Completed NCT00713778 Phase 4
15 A Random Clinical Trial (RCT) of the Impact of Electrocoagulation on Ovarian Reserve Completed NCT00746278 Phase 4
16 Clinical Evaluation of Furocyst in Patients With Poly Cystic Ovary Syndrome Completed NCT02789488 Phase 4
17 The Role of Estrogen in Luteinizing Hormone Surge and Ovulation Completed NCT01999569 Phase 4 Letrozole
18 Danazol Treatment in Endometriosis Women Before IVF Completed NCT01779232 Phase 4 Danazol;placebo
19 Pain Post Abdominal Laparoscopy Prevention With Arcoxia Completed NCT00565682 Phase 4 etoricoxib 120 mg
20 FSH/LH Ratio as a Predictor of IVF Outcome in Young and Older Women Completed NCT02674178 Phase 4
21 Effects of Metformin Plus Simvastatin on Polycystic Ovarian Syndrome (PCOS): A Prospective, Randomized, Double-Blind, Placebo-Controlled Study Completed NCT01021579 Phase 4 Metformin plus Placebo;Metfomin plus Simvastatin
22 The Effect of Ethinyl Estradiol on Polycystic Ovary Syndrome Women Undergoing Intrauterine Insemination Completed NCT01219101 Phase 4 clomiphene citrate with ethinyl esteradiol;clomiphene citrate with plasebo
23 Vitamin D Increases Serum Levels of the Soluble Receptor for Advanced Glycation End Products in Women With PCOS Completed NCT03644212 Phase 4 Vitamin D3
24 Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome Completed NCT03122041 Phase 4 Sitagliptin
25 Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss Completed NCT02941445 Phase 4 sitagliptin and metformin;Metformin
26 The Effect of Metformin on Different Hormones in PCOS Patients Completed NCT02568488 Phase 4 Metformin
27 Liraglutide as Add on Therapy on Metformin in Women With Polycystic Ovary Syndrome Completed NCT02483299 Phase 4 Metformin;Glucophage tablets and Victoza
28 Phytoestrogens as an Alternative to Estradiol in Ovulation Induction in PCOS Completed NCT02352597 Phase 4 phytoestrogen;estradiol valerate;clomiphene citrate
29 PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary Syndrome Completed NCT02187250 Phase 4 metformin;liraglutide;roflumilast
30 PDE-4 Inhibitor Roflumilast and Polycystic Ovary Syndrome Completed NCT02037672 Phase 4 metformin;metformin and roflumilast
31 Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on Metformin Completed NCT01911468 Phase 4 metformin;liraglutide;metformin and liraglutide
32 Polycystic Ovary Syndrome and Liraglutide Completed NCT01899430 Phase 4 liraglutide;metformin
33 Vitamin D Treatment, Pharmacogenetics and Glucose Metabolism Completed NCT01721915 Phase 4 Vitamin D supplementation;Placebo
34 Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women Completed NCT01675310 Phase 4 medical nutrition therapy + metformin
35 hMG or Recombinant FSH on OHSS Prevention in PCOS Patients Undergoing IVF Completed NCT01365936 Phase 4 HMG;rFSH
36 Adding L-Carnitine to Clomiphene Citrate for Induction of Ovulation in Women With Polycystic Ovary Syndrome Completed NCT03630341 Phase 4 Clomiphene Citrate 50mg;L-carnitine;Placebo Oral Tablet
37 The Effect of a Liraglutide on IVF in Obese PCOS Completed NCT03353948 Phase 4 MET;COMBI
38 Oral Contraceptive and Cardiovascular Risk in PCOS Completed NCT00593294 Phase 4 OC - Drospirenone plus Ethynylestradiol
39 The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOS Completed NCT02866786 Phase 4 Metformin;ethinyl estradiol and cyproterone acetate
40 Metformin and Oral Contraceptives in PCOS Completed NCT00451568 Phase 4 Metformin;Desorelle
41 The Effects of Vitamin D on Angiogenic Factors in Women With Polycystic Ovary Syndrome Completed NCT02460380 Phase 4 Vitamin D3
42 Trial With Metformin in Women With Polycystic Ovary Syndrome Completed NCT02280057 Phase 4 Metformin;Placebo
43 N-acetyl Cysteine for Ovulation Induction in Clomiphene Citrate Resistant Polycystic Ovary Syndrome Completed NCT02239107 Phase 4 N-Acetyl cysteine
44 LIPT - Liraglutide in Polycystic Ovary Syndrome Completed NCT02073929 Phase 4 Liraglutide;placebo
45 The Effect of Cipralex on Quality of Life, Adrenal Activity Glucose Metabolism, Physical and Mental Health in PCOS Completed NCT01961180 Phase 4 Cipralex;Placebo
46 Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance of Metformin Treated Women With PCOS Completed NCT02683226 Phase 4 Vipdomet;Incresync
47 Role of Melatonin Supplementation in Follicular Fluid of in Vitro Fertilization (IVF) Patients With Polycystic Ovarian Syndrome Completed NCT01540747 Phase 4
48 Polycystic Ovary Syndrome - Improving Outcomes Completed NCT01504321 Phase 4 Moxonidine;Placebo
49 Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism Completed NCT01360996 Phase 4 3 mg DRSP/20 μg EE
50 Metformin Versus Acarbose Treatment in Infertile Overweight Women With Polycystic Ovary Syndrome (PCOS) Completed NCT01279512 Phase 4 Metformin;Acarbose

Search NIH Clinical Center for Ovarian Cyst

Cochrane evidence based reviews: ovarian cysts

Genetic Tests for Ovarian Cyst

Genetic tests related to Ovarian Cyst:

# Genetic test Affiliating Genes
1 Ovarian Cyst 29

Anatomical Context for Ovarian Cyst

MalaCards organs/tissues related to Ovarian Cyst:

41
Ovary, Pituitary, Uterus, Bone, Kidney, Thyroid, Appendix

The Foundational Model of Anatomy Ontology organs/tissues related to Ovarian Cyst:

19
The Ovary

Publications for Ovarian Cyst

Articles related to Ovarian Cyst:

(show top 50) (show all 1370)
# Title Authors Year
1
The effects of sclerotherapy with 5% trichloroacetic acid on the cyst diameter and ovarian tissue in the rat ovarian cyst model. ( 29564948 )
2018
2
Vaginal bleeding and a giant ovarian cyst in an infant with 21-hydroxylase deficiency. ( 29252197 )
2018
3
Omental fat necrosis without torsion mimicking ovarian cyst torsion. ( 29685724 )
2018
4
Ovarian cyst removal influences ovarian reserve dependent on histology, size and type of operation. ( 29806554 )
2018
5
A Giant Ovarian Cyst in an Adolescent. ( 29731358 )
2018
6
High Frequency of Ovarian Cyst Development in Vhl2B/+;Snf5+/- Mice. ( 29684361 )
2018
7
Successful treatment of a giant ovarian cyst by levothyroxin in a young adult woman: A case report. ( 30051551 )
2018
8
The effect of tamoxifen therapy on the endometrium and ovarian cyst formation in patients with breast cancer. ( 30254998 )
2018
9
Histological classification of canine ovarian cyst types with reference to medical history. ( 30304884 )
2018
10
Fishnet/cobweb ovary: Haemorrhagic ovarian cyst. ( 30309168 )
2018
11
High Incidence of Ovarian Cysts in Women Receiving mTOR Inhibitors After Renal Transplantation. ( 29087803 )
2018
12
Daughter cyst sign in ovarian cysts. ( 29198005 )
2018
13
In-utero aspiration vs expectant management of anechoic fetal ovarian cysts: open randomized controlled trial. ( 29205608 )
2018
14
A retrospective multicenter study of the natural history of fetal ovarian cysts. ( 29534823 )
2018
15
Anti-Müllerian hormone levels and spontaneous pregnancy in women undergoing surgery for benign ovarian cysts. ( 29724140 )
2018
16
Variation in Downstream Relative Costs Associated With Incidental Ovarian Cysts on Ultrasound. ( 29728324 )
2018
17
Diagnostic value of neutrophil to lymphocyte ratio in differentiation of ruptured ovarian cysts and adnexal torsion. ( 29971185 )
2018
18
Re: In-utero aspiration vs expectant management of anechoic fetal ovarian cysts: open randomized controlled trial. C. Diguisto , N. Winer , G. Benoist , H. Laurichesse-Delmas , J. Potin , A. Binet , H. Lardy , B. Morel and F. Perrotin . Ultrasound Obstet Gynecol 2018; 52: 159-164. ( 30095235 )
2018
19
The Evaluation of Laparoscopic Surgery on Pregnant Patients with Ovarian Cysts and Its Effects on Pregnancy over the Past 5 Years. ( 30254926 )
2018
20
How long should we follow simple ovarian cysts with pelvic ultrasonography? ( 30289754 )
2018
21
Suggestive hypothesis on a case report: Patient presenting with cyclical ovarian cysts coupled to increased cholestatic enzymes. ( 30393940 )
2018
22
Assessment of Diagnostic Values among CA-125, RMI, HE4, and ROMA for Cancer Prediction in Women with Nonfunctional Ovarian Cysts. ( 30402106 )
2018
23
Impending abdominal compartment syndrome from a giant ovarian cyst torsion. ( 28922702 )
2017
24
Case Report of Clitoral Hypertrophy in 2 Extremely Premature Girls With an Ovarian Cyst. ( 28931575 )
2017
25
Performance of ovarian cyst fluid fine-needle aspiration cytology. ( 28834408 )
2017
26
Haemoperitoneum due to ruptured ovarian cyst in a 13-year-old girl with factor V deficiency- A case report. ( 28138193 )
2017
27
Laparoscopic Management of a Giant Ovarian Cyst in a Premenarchal Girl. ( 28104495 )
2017
28
A Wandering Abdominal Mass in a Neonate: An Enteric Duplication Cyst Mimicking an Ovarian Cyst. ( 28348910 )
2017
29
Diagnostic accuracy of haptoglobin within ovarian cyst fluid as a potential point-of-care test for epithelial ovarian cancer: an observational study. ( 28755436 )
2017
30
Complete Laparoscopic Extirpation of a Giant Ovarian Cyst in an Adolescent. ( 28840047 )
2017
31
Presacral mass in the setting of an ovarian cyst and abdominal pain. ( 28659365 )
2017
32
Enormous Ovarian Cyst. ( 29021455 )
2017
33
Treatment of Recurrent Ovarian Cysts and Primary Infertility by Iranian Traditional Medicine: A Case Report. ( 27932523 )
2017
34
Papillary Serous Carcinoma of the Peritoneum Mimicking an Ovarian Cyst in Pregnancy. ( 27133555 )
2017
35
Hemorrhage in a Fetal Ovarian Cyst. ( 28770146 )
2017
36
Giant ovarian cyst masquerading as a massive ascites: a case report. ( 29258579 )
2017
37
The relationship between functional ovarian cysts and vitamin A, vitamin E, and folate intake. ( 27924658 )
2017
38
Neonatal ovarian cysts: ultrasound assessment and differential diagnosis. ( 28024877 )
2017
39
Age-Specific Frequencies and Characteristics of Ovarian Cysts in Children and Adolescents. ( 28044991 )
2017
40
Management of Complex Ovarian Cysts in Newborns - Our Experience. ( 28083489 )
2017
41
Evaluation and Treatment Results of Ovarian Cysts in Childhood and Adolescence: A Multicenter, Retrospective Study of 100 Patients. ( 28167139 )
2017
42
The Diagnosis and Management of Ovarian Cysts in Children. ( 28214196 )
2017
43
Bilateral Ovarian Torsion during Follow-up for Antenatally Detected Ovarian Cysts. ( 28540192 )
2017
44
Effect of menstrual phase on the surgical treatment of ovarian cysts. ( 28597715 )
2017
45
Comparative Gene Expression Analysis of Lymphocytes Treated with Exosomes Derived from Ovarian Cancer and Ovarian Cysts. ( 28620375 )
2017
46
Microarray analysis reveals differentially expressed lncRNAs in benign epithelial ovarian cysts and normal ovaries. ( 28656240 )
2017
47
The presence of ovarian cysts in a captive Antillean manatee (Trichechus manatus manatus L. 1758). ( 28810859 )
2017
48
A systematic review and meta-analysis on fetal ovarian cysts: impact of size, appearance and prenatal aspiration. ( 28886226 )
2017
49
Outcome of fetal ovarian cysts diagnosed on prenatal ultrasound examination: systematic review and meta-analysis. ( 27325566 )
2017
50
LncRNAs expression profiling in normal ovary, benign ovarian cyst and malignant epithelial ovarian cancer. ( 27941916 )
2016

Variations for Ovarian Cyst

Expression for Ovarian Cyst

Search GEO for disease gene expression data for Ovarian Cyst.

Pathways for Ovarian Cyst

Pathways related to Ovarian Cyst according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.51 PLAT PLAU SERPINB2 VEGFA
2
Show member pathways
11.78 PLAT PLAU SERPINB2
3 11.64 PLAT PLAU SERPINB2
4 11.46 PLAT PLAU SERPINB2
5 11.26 PLAT PLAU
6 11.14 PLAT PLAU
7 11.14 PLAT PLAU VEGFA
8 10.82 PLAT PLAU VEGFA
9 10.62 PLAT VEGFA
10 9.91 PLAT PLAU SERPINB2

GO Terms for Ovarian Cyst

Cellular components related to Ovarian Cyst according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.5 AFP MUC16 PLAT PLAU PRL SERPINB2
2 secretory granule GO:0030141 9.33 PLAT PRL VEGFA
3 extracellular space GO:0005615 9.17 AFP MUC16 PLAT PLAU PRL SERPINB2

Biological processes related to Ovarian Cyst according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 response to hypoxia GO:0001666 9.43 PLAT PLAU VEGFA
2 positive regulation of epithelial cell proliferation GO:0050679 9.4 PRL VEGFA
3 lactation GO:0007595 9.37 PRL VEGFA
4 ovarian follicle development GO:0001541 9.32 FOXL2 VEGFA
5 plasminogen activation GO:0031639 9.16 PLAT PLAU
6 smooth muscle cell migration GO:0014909 8.96 PLAT PLAU
7 fibrinolysis GO:0042730 8.8 PLAT PLAU SERPINB2

Sources for Ovarian Cyst

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....